EZEKIEL LOPEZ: Open Payments
NPI 1588442388 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 38 payments from 17 companies in 2025. Trend: 2023 $196 · 2024 $873 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $201 |
| Dendreon Pharmaceuticals LLC | 3 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| PFIZER INC. | 2 | $56 |
| Endo USA, Inc. | 3 | $50 |
| ABBVIE INC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Antares Pharma, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: GEMTESA, PROVENGE, Nubeqa, Xtandi, BOTOX, LYNPARZA, ADSTILADRIN, XYOSTED.
Industry payments across LA — which companies pay providers there.
